

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sulfation (GO:0051923) | 7.02938921 |
| 2 | behavioral response to nicotine (GO:0035095) | 6.93616671 |
| 3 | cellular response to ATP (GO:0071318) | 6.81846279 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.32718140 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.05680882 |
| 6 | synaptic vesicle maturation (GO:0016188) | 6.05076467 |
| 7 | regulation of glomerulus development (GO:0090192) | 6.03903151 |
| 8 | locomotory exploration behavior (GO:0035641) | 5.93227247 |
| 9 | cell proliferation in forebrain (GO:0021846) | 5.91046096 |
| 10 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.76388186 |
| 11 | vocalization behavior (GO:0071625) | 5.66598756 |
| 12 | regulation of cell proliferation involved in kidney development (GO:1901722) | 5.63682804 |
| 13 | synaptic vesicle exocytosis (GO:0016079) | 5.50267327 |
| 14 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.50083132 |
| 15 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.47020088 |
| 16 | glutamate secretion (GO:0014047) | 5.41022233 |
| 17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.40978855 |
| 18 | neuronal action potential propagation (GO:0019227) | 5.15104356 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.12429586 |
| 20 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.07423716 |
| 21 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.05359698 |
| 22 | regulation of phospholipid biosynthetic process (GO:0071071) | 5.02429328 |
| 23 | positive regulation of fatty acid oxidation (GO:0046321) | 5.00472028 |
| 24 | protein localization to synapse (GO:0035418) | 4.87265941 |
| 25 | opsonization (GO:0008228) | 4.86397269 |
| 26 | regulation of posttranscriptional gene silencing (GO:0060147) | 4.78892277 |
| 27 | regulation of gene silencing by miRNA (GO:0060964) | 4.78892277 |
| 28 | regulation of gene silencing by RNA (GO:0060966) | 4.78892277 |
| 29 | negative regulation of hormone biosynthetic process (GO:0032353) | 4.69979823 |
| 30 | cellular anion homeostasis (GO:0030002) | 4.64808497 |
| 31 | positive regulation of metanephros development (GO:0072216) | 4.64468727 |
| 32 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.63364912 |
| 33 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.62590998 |
| 34 | synaptic transmission, glutamatergic (GO:0035249) | 4.57363355 |
| 35 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 4.56872217 |
| 36 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.55550470 |
| 37 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.55550470 |
| 38 | tooth mineralization (GO:0034505) | 4.55078946 |
| 39 | regulation of synaptic vesicle transport (GO:1902803) | 4.54588336 |
| 40 | serotonin metabolic process (GO:0042428) | 4.52384971 |
| 41 | glutamate receptor signaling pathway (GO:0007215) | 4.50433524 |
| 42 | exploration behavior (GO:0035640) | 4.49762223 |
| 43 | neurotransmitter secretion (GO:0007269) | 4.48709339 |
| 44 | neuron cell-cell adhesion (GO:0007158) | 4.41315949 |
| 45 | negative regulation of systemic arterial blood pressure (GO:0003085) | 4.33946038 |
| 46 | pharyngeal system development (GO:0060037) | 4.28044504 |
| 47 | neuron-neuron synaptic transmission (GO:0007270) | 4.26050752 |
| 48 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.25322577 |
| 49 | regulation of synapse structural plasticity (GO:0051823) | 4.25207394 |
| 50 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.24190586 |
| 51 | negative regulation of appetite (GO:0032099) | 4.23973830 |
| 52 | negative regulation of response to food (GO:0032096) | 4.23973830 |
| 53 | long-term memory (GO:0007616) | 4.20420030 |
| 54 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.13034533 |
| 55 | response to UV-C (GO:0010225) | 4.13004271 |
| 56 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.12774477 |
| 57 | multicellular organismal movement (GO:0050879) | 4.12068262 |
| 58 | musculoskeletal movement (GO:0050881) | 4.12068262 |
| 59 | dendritic spine morphogenesis (GO:0060997) | 4.10402619 |
| 60 | positive regulation of membrane potential (GO:0045838) | 4.07911874 |
| 61 | flavonoid metabolic process (GO:0009812) | 4.07012571 |
| 62 | negative regulation of hormone metabolic process (GO:0032351) | 4.05915726 |
| 63 | layer formation in cerebral cortex (GO:0021819) | 4.00896001 |
| 64 | cellular potassium ion homeostasis (GO:0030007) | 3.97849798 |
| 65 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.97064884 |
| 66 | gamma-aminobutyric acid transport (GO:0015812) | 3.94708778 |
| 67 | regulation of postsynaptic membrane potential (GO:0060078) | 3.90802701 |
| 68 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 3.87974941 |
| 69 | primary amino compound metabolic process (GO:1901160) | 3.87673311 |
| 70 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.85701593 |
| 71 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.85554389 |
| 72 | regulation of sequestering of triglyceride (GO:0010889) | 3.85114032 |
| 73 | regulation of synaptic plasticity (GO:0048167) | 3.78665731 |
| 74 | plasma membrane repair (GO:0001778) | 3.78561074 |
| 75 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.75653699 |
| 76 | proline transport (GO:0015824) | 3.73462192 |
| 77 | kynurenine metabolic process (GO:0070189) | 3.68434196 |
| 78 | otic vesicle formation (GO:0030916) | 3.65216586 |
| 79 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.62096479 |
| 80 | sodium ion export (GO:0071436) | 3.60858640 |
| 81 | activation of protein kinase A activity (GO:0034199) | 3.60624952 |
| 82 | neurotransmitter transport (GO:0006836) | 3.60236288 |
| 83 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.60091562 |
| 84 | neuromuscular process controlling balance (GO:0050885) | 3.60001504 |
| 85 | positive regulation of synapse maturation (GO:0090129) | 3.56881668 |
| 86 | long-term synaptic potentiation (GO:0060291) | 3.53722227 |
| 87 | transmission of nerve impulse (GO:0019226) | 3.53120944 |
| 88 | regulation of neurotransmitter secretion (GO:0046928) | 3.52829470 |
| 89 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.50979863 |
| 90 | synaptic vesicle endocytosis (GO:0048488) | 3.50907999 |
| 91 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.49726104 |
| 92 | regulation of DNA endoreduplication (GO:0032875) | 3.49645744 |
| 93 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.49621056 |
| 94 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.49376737 |
| 95 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.48963800 |
| 96 | neuromuscular process controlling posture (GO:0050884) | 3.48019975 |
| 97 | neuronal ion channel clustering (GO:0045161) | 3.47827446 |
| 98 | positive regulation of neurotransmitter transport (GO:0051590) | 3.46367782 |
| 99 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.46263850 |
| 100 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.46032686 |
| 101 | indole-containing compound metabolic process (GO:0042430) | 3.42966600 |
| 102 | tryptophan catabolic process (GO:0006569) | 3.42845672 |
| 103 | indole-containing compound catabolic process (GO:0042436) | 3.42845672 |
| 104 | indolalkylamine catabolic process (GO:0046218) | 3.42845672 |
| 105 | auditory behavior (GO:0031223) | 3.42368859 |
| 106 | membrane depolarization during action potential (GO:0086010) | 3.41933045 |
| 107 | neuron recognition (GO:0008038) | 3.41518863 |
| 108 | membrane depolarization (GO:0051899) | 3.40699675 |
| 109 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.37959274 |
| 110 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.36540154 |
| 111 | regulation of collateral sprouting (GO:0048670) | 3.36524690 |
| 112 | regulation of neurotransmitter levels (GO:0001505) | 3.35504972 |
| 113 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.35371147 |
| 114 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.35185987 |
| 115 | regulation of hippo signaling (GO:0035330) | 3.34182493 |
| 116 | negative chemotaxis (GO:0050919) | 3.32721418 |
| 117 | regulation of DNA damage checkpoint (GO:2000001) | 3.30445253 |
| 118 | regulation of metanephros development (GO:0072215) | 3.30246164 |
| 119 | prepulse inhibition (GO:0060134) | 3.28691666 |
| 120 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.28440015 |
| 121 | negative regulation of gene silencing (GO:0060969) | 3.28421679 |
| 122 | regulation of neurotransmitter transport (GO:0051588) | 3.28081383 |
| 123 | regulation of dendritic spine development (GO:0060998) | 3.26514901 |
| 124 | response to auditory stimulus (GO:0010996) | 3.25939600 |
| 125 | regulation of vesicle fusion (GO:0031338) | 3.25241229 |
| 126 | glycine transport (GO:0015816) | 3.25195845 |
| 127 | reflex (GO:0060004) | 3.24056072 |
| 128 | postsynaptic membrane organization (GO:0001941) | 3.23703950 |
| 129 | negative regulation of platelet activation (GO:0010544) | 3.23339636 |
| 130 | dorsal/ventral axis specification (GO:0009950) | 3.22622010 |
| 131 | positive regulation of dendritic spine development (GO:0060999) | 3.21940705 |
| 132 | membrane hyperpolarization (GO:0060081) | 3.21861705 |
| 133 | somite development (GO:0061053) | 3.21313961 |
| 134 | dendritic spine organization (GO:0097061) | 3.19974708 |
| 135 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.17647075 |
| 136 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.17397454 |
| 137 | lateral sprouting from an epithelium (GO:0060601) | 3.16499415 |
| 138 | learning (GO:0007612) | 3.16488015 |
| 139 | behavioral fear response (GO:0001662) | 3.16214642 |
| 140 | behavioral defense response (GO:0002209) | 3.16214642 |
| 141 | cell communication by electrical coupling (GO:0010644) | 3.14734096 |
| 142 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.14718251 |
| 143 | axonal fasciculation (GO:0007413) | 3.14456391 |
| 144 | cell differentiation in hindbrain (GO:0021533) | 3.13941123 |
| 145 | peristalsis (GO:0030432) | 3.12511686 |
| 146 | neuronal action potential (GO:0019228) | 3.12354008 |
| 147 | chemosensory behavior (GO:0007635) | 3.12123167 |
| 148 | positive regulation of synaptic transmission (GO:0050806) | 3.10441593 |
| 149 | protein polyglutamylation (GO:0018095) | 3.08849532 |
| 150 | spinal cord motor neuron differentiation (GO:0021522) | 3.08445527 |
| 151 | innervation (GO:0060384) | 3.07851742 |
| 152 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.07757956 |
| 153 | response to histamine (GO:0034776) | 3.07689649 |
| 154 | regulation of synaptic transmission (GO:0050804) | 3.07562681 |
| 155 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.07220589 |
| 156 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.06927936 |
| 157 | synaptic transmission (GO:0007268) | 3.06876166 |
| 158 | neuromuscular process (GO:0050905) | 3.05696967 |
| 159 | dentate gyrus development (GO:0021542) | 3.05616532 |
| 160 | behavioral response to cocaine (GO:0048148) | 3.05091581 |
| 161 | lung morphogenesis (GO:0060425) | 3.04639882 |
| 162 | L-amino acid import (GO:0043092) | 3.03888793 |
| 163 | regulation of female receptivity (GO:0045924) | 3.00589615 |
| 164 | intraspecies interaction between organisms (GO:0051703) | 3.00448811 |
| 165 | social behavior (GO:0035176) | 3.00448811 |
| 166 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.99840559 |
| 167 | behavioral response to pain (GO:0048266) | 2.97049718 |
| 168 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.95852804 |
| 169 | negative regulation of cardiac muscle tissue development (GO:0055026) | 2.94328371 |
| 170 | indolalkylamine metabolic process (GO:0006586) | 2.92905820 |
| 171 | presynaptic membrane assembly (GO:0097105) | 2.91360618 |
| 172 | embryonic hindlimb morphogenesis (GO:0035116) | 2.89149188 |
| 173 | neuromuscular synaptic transmission (GO:0007274) | 2.86853661 |
| 174 | regulation of response to food (GO:0032095) | 2.86112544 |
| 175 | angiogenesis involved in wound healing (GO:0060055) | 2.85991211 |
| 176 | renal system development (GO:0072001) | 2.82841343 |
| 177 | negative regulation by host of viral transcription (GO:0043922) | 2.80521688 |
| 178 | positive regulation of protein autophosphorylation (GO:0031954) | 2.79320496 |
| 179 | pituitary gland development (GO:0021983) | 2.79264477 |
| 180 | regulation of neurotransmitter uptake (GO:0051580) | 2.78737697 |
| 181 | startle response (GO:0001964) | 2.74196656 |
| 182 | positive regulation of gluconeogenesis (GO:0045722) | 2.74125820 |
| 183 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.73233609 |
| 184 | tryptophan metabolic process (GO:0006568) | 2.73142684 |
| 185 | N-acetylglucosamine metabolic process (GO:0006044) | 2.71919205 |
| 186 | positive regulation of glomerulus development (GO:0090193) | 2.71760463 |
| 187 | prostate gland growth (GO:0060736) | 2.69645211 |
| 188 | limb bud formation (GO:0060174) | 2.68744566 |
| 189 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.68222940 |
| 190 | aorta morphogenesis (GO:0035909) | 2.65765971 |
| 191 | regulation of transcription regulatory region DNA binding (GO:2000677) | 2.64092938 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.23174946 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.52718719 |
| 3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.47387647 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.19219319 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.17186375 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.12439786 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.86039755 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.84455808 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.82373412 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.82373412 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.74044113 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.72759749 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.65727202 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.58785150 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.58205122 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.51819576 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.49722298 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.49339475 |
| 19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.33304567 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.32609303 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.30278266 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.28081679 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.27914168 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.24803845 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.15938299 |
| 26 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.13912779 |
| 27 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.03506518 |
| 28 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.02689412 |
| 29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.01662114 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.95983790 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.94997327 |
| 32 | FUS_26573619_Chip-Seq_HEK293_Human | 1.94611702 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.93080062 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.73615699 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.70243467 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66751684 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.65832191 |
| 38 | EWS_26573619_Chip-Seq_HEK293_Human | 1.64869612 |
| 39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.61915694 |
| 40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59678582 |
| 41 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.59449689 |
| 42 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.57131833 |
| 43 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.49284071 |
| 44 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.38225567 |
| 45 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.35133669 |
| 46 | KDM2B_26808549_Chip-Seq_REH_Human | 1.34082196 |
| 47 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.32415897 |
| 48 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.30675903 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30317573 |
| 50 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.28534538 |
| 51 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.27786355 |
| 52 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27713015 |
| 53 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27226538 |
| 54 | VDR_22108803_ChIP-Seq_LS180_Human | 1.26605280 |
| 55 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26190681 |
| 56 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25675715 |
| 57 | P300_19829295_ChIP-Seq_ESCs_Human | 1.23993150 |
| 58 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.23172301 |
| 59 | AR_19668381_ChIP-Seq_PC3_Human | 1.22673043 |
| 60 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.22488904 |
| 61 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22153112 |
| 62 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.22062551 |
| 63 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.22062551 |
| 64 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.21832007 |
| 65 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.20766375 |
| 66 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.19006063 |
| 67 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.18664262 |
| 68 | AR_25329375_ChIP-Seq_VCAP_Human | 1.18595200 |
| 69 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18359162 |
| 70 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.18140789 |
| 71 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17800303 |
| 72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17047095 |
| 73 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.16848470 |
| 74 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.16396228 |
| 75 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.16296067 |
| 76 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12937250 |
| 77 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.12897875 |
| 78 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.12336499 |
| 79 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11521065 |
| 80 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10289654 |
| 81 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.09909455 |
| 82 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.08689607 |
| 83 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08611342 |
| 84 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08411015 |
| 85 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07099580 |
| 86 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.06787104 |
| 87 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06298873 |
| 88 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04991865 |
| 89 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04644581 |
| 90 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.04057717 |
| 91 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03877674 |
| 92 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03869469 |
| 93 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02976699 |
| 94 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02788370 |
| 95 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02652677 |
| 96 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02560728 |
| 97 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.02177701 |
| 98 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.01134666 |
| 99 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00991909 |
| 100 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00473012 |
| 101 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.00026951 |
| 102 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.99787656 |
| 103 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99598798 |
| 104 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98650477 |
| 105 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.98486941 |
| 106 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.97944393 |
| 107 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97265689 |
| 108 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97208076 |
| 109 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97010129 |
| 110 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96053647 |
| 111 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94647386 |
| 112 | TP53_16413492_ChIP-PET_HCT116_Human | 0.93689444 |
| 113 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93517792 |
| 114 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.93008705 |
| 115 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.92727145 |
| 116 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90130945 |
| 117 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89960473 |
| 118 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89685590 |
| 119 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89582708 |
| 120 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.89339778 |
| 121 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88527019 |
| 122 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87223899 |
| 123 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.85543160 |
| 124 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.85327088 |
| 125 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84906555 |
| 126 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83986619 |
| 127 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.83986619 |
| 128 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.82798022 |
| 129 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.82139108 |
| 130 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.81247522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.01433367 |
| 2 | MP0003880_abnormal_central_pattern | 5.01718073 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.32778567 |
| 4 | MP0004270_analgesia | 3.97068586 |
| 5 | MP0009745_abnormal_behavioral_response | 3.57132920 |
| 6 | MP0004134_abnormal_chest_morphology | 3.50965321 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.46626214 |
| 8 | MP0002064_seizures | 3.28188454 |
| 9 | MP0009046_muscle_twitch | 3.27871741 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.20861688 |
| 11 | MP0002822_catalepsy | 3.14703767 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.93598014 |
| 13 | MP0002272_abnormal_nervous_system | 2.78109332 |
| 14 | MP0006292_abnormal_olfactory_placode | 2.77042223 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.73718550 |
| 16 | MP0001486_abnormal_startle_reflex | 2.73493235 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.62855726 |
| 18 | MP0000049_abnormal_middle_ear | 2.61700561 |
| 19 | MP0004130_abnormal_muscle_cell | 2.52475391 |
| 20 | MP0002736_abnormal_nociception_after | 2.46533380 |
| 21 | MP0001501_abnormal_sleep_pattern | 2.44805268 |
| 22 | MP0002735_abnormal_chemical_nociception | 2.34969386 |
| 23 | MP0002160_abnormal_reproductive_system | 2.29247041 |
| 24 | MP0009250_abnormal_appendicular_skeleto | 2.25069208 |
| 25 | MP0003195_calcinosis | 2.23607063 |
| 26 | MP0003646_muscle_fatigue | 2.17991076 |
| 27 | MP0001440_abnormal_grooming_behavior | 2.17588629 |
| 28 | MP0002733_abnormal_thermal_nociception | 2.06640461 |
| 29 | MP0002067_abnormal_sensory_capabilities | 2.02730690 |
| 30 | MP0001970_abnormal_pain_threshold | 2.02065646 |
| 31 | MP0008569_lethality_at_weaning | 1.99792319 |
| 32 | MP0000678_abnormal_parathyroid_gland | 1.99520216 |
| 33 | MP0002089_abnormal_postnatal_growth/wei | 1.90649317 |
| 34 | MP0004133_heterotaxia | 1.90498391 |
| 35 | MP0003329_amyloid_beta_deposits | 1.89618378 |
| 36 | MP0003879_abnormal_hair_cell | 1.88478158 |
| 37 | MP0004858_abnormal_nervous_system | 1.82227422 |
| 38 | MP0002184_abnormal_innervation | 1.77420875 |
| 39 | MP0004811_abnormal_neuron_physiology | 1.75976534 |
| 40 | MP0002249_abnormal_larynx_morphology | 1.75512150 |
| 41 | MP0009780_abnormal_chondrocyte_physiolo | 1.74189257 |
| 42 | MP0002557_abnormal_social/conspecific_i | 1.73380154 |
| 43 | MP0002876_abnormal_thyroid_physiology | 1.70139058 |
| 44 | MP0005386_behavior/neurological_phenoty | 1.68278582 |
| 45 | MP0004924_abnormal_behavior | 1.68278582 |
| 46 | MP0003938_abnormal_ear_development | 1.66590892 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.66169117 |
| 48 | MP0000537_abnormal_urethra_morphology | 1.61257735 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.60392181 |
| 50 | MP0003638_abnormal_response/metabolism_ | 1.59007539 |
| 51 | MP0000778_abnormal_nervous_system | 1.56908851 |
| 52 | MP0005646_abnormal_pituitary_gland | 1.55740313 |
| 53 | MP0003119_abnormal_digestive_system | 1.55214197 |
| 54 | MP0001984_abnormal_olfaction | 1.54341412 |
| 55 | MP0000955_abnormal_spinal_cord | 1.52518230 |
| 56 | MP0009053_abnormal_anal_canal | 1.47415037 |
| 57 | MP0005389_reproductive_system_phenotype | 1.46871867 |
| 58 | MP0006276_abnormal_autonomic_nervous | 1.45061152 |
| 59 | MP0002066_abnormal_motor_capabilities/c | 1.44027279 |
| 60 | MP0003633_abnormal_nervous_system | 1.40538125 |
| 61 | MP0002882_abnormal_neuron_morphology | 1.38967004 |
| 62 | MP0003937_abnormal_limbs/digits/tail_de | 1.37376734 |
| 63 | MP0005670_abnormal_white_adipose | 1.36573074 |
| 64 | MP0004885_abnormal_endolymph | 1.33276631 |
| 65 | MP0003787_abnormal_imprinting | 1.33056019 |
| 66 | MP0001529_abnormal_vocalization | 1.30937823 |
| 67 | MP0003890_abnormal_embryonic-extraembry | 1.29627656 |
| 68 | MP0009384_cardiac_valve_regurgitation | 1.28616616 |
| 69 | MP0008877_abnormal_DNA_methylation | 1.28595710 |
| 70 | MP0003942_abnormal_urinary_system | 1.26713539 |
| 71 | MP0004142_abnormal_muscle_tone | 1.24261119 |
| 72 | MP0000026_abnormal_inner_ear | 1.22953457 |
| 73 | MP0005645_abnormal_hypothalamus_physiol | 1.21156422 |
| 74 | MP0001502_abnormal_circadian_rhythm | 1.19662404 |
| 75 | MP0003631_nervous_system_phenotype | 1.18504963 |
| 76 | MP0000013_abnormal_adipose_tissue | 1.18474761 |
| 77 | MP0009379_abnormal_foot_pigmentation | 1.13567824 |
| 78 | MP0001905_abnormal_dopamine_level | 1.13545420 |
| 79 | MP0002282_abnormal_trachea_morphology | 1.12345565 |
| 80 | MP0008872_abnormal_physiological_respon | 1.11569793 |
| 81 | MP0000613_abnormal_salivary_gland | 1.11170324 |
| 82 | MP0004145_abnormal_muscle_electrophysio | 1.09320818 |
| 83 | MP0000733_abnormal_muscle_development | 1.06896050 |
| 84 | MP0002928_abnormal_bile_duct | 1.05865119 |
| 85 | MP0002152_abnormal_brain_morphology | 1.05317369 |
| 86 | MP0002102_abnormal_ear_morphology | 1.04031514 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 1.03978503 |
| 88 | MP0000534_abnormal_ureter_morphology | 1.03759085 |
| 89 | MP0000751_myopathy | 1.03509523 |
| 90 | MP0002653_abnormal_ependyma_morphology | 1.03215341 |
| 91 | MP0008874_decreased_physiological_sensi | 1.00976054 |
| 92 | MP0000569_abnormal_digit_pigmentation | 0.99613941 |
| 93 | MP0002229_neurodegeneration | 0.98973863 |
| 94 | MP0002116_abnormal_craniofacial_bone | 0.97254823 |
| 95 | MP0002163_abnormal_gland_morphology | 0.97183244 |
| 96 | MP0003075_altered_response_to | 0.96492106 |
| 97 | MP0000681_abnormal_thyroid_gland | 0.94667020 |
| 98 | MP0004742_abnormal_vestibular_system | 0.94233272 |
| 99 | MP0003283_abnormal_digestive_organ | 0.94205778 |
| 100 | MP0002069_abnormal_eating/drinking_beha | 0.93720510 |
| 101 | MP0001986_abnormal_taste_sensitivity | 0.92230123 |
| 102 | MP0008961_abnormal_basal_metabolism | 0.91160875 |
| 103 | MP0005448_abnormal_energy_balance | 0.90210318 |
| 104 | MP0001485_abnormal_pinna_reflex | 0.89371138 |
| 105 | MP0003122_maternal_imprinting | 0.88882718 |
| 106 | MP0001177_atelectasis | 0.88247968 |
| 107 | MP0001188_hyperpigmentation | 0.87915024 |
| 108 | MP0005551_abnormal_eye_electrophysiolog | 0.87275355 |
| 109 | MP0002751_abnormal_autonomic_nervous | 0.86521292 |
| 110 | MP0010386_abnormal_urinary_bladder | 0.85174367 |
| 111 | MP0005535_abnormal_body_temperature | 0.84702880 |
| 112 | MP0000604_amyloidosis | 0.84631997 |
| 113 | MP0003011_delayed_dark_adaptation | 0.83195567 |
| 114 | MP0003632_abnormal_nervous_system | 0.82736577 |
| 115 | MP0003936_abnormal_reproductive_system | 0.82080517 |
| 116 | MP0000920_abnormal_myelination | 0.81955770 |
| 117 | MP0001963_abnormal_hearing_physiology | 0.81569175 |
| 118 | MP0004085_abnormal_heartbeat | 0.80127978 |
| 119 | MP0003690_abnormal_glial_cell | 0.79536938 |
| 120 | MP0005174_abnormal_tail_pigmentation | 0.78898214 |
| 121 | MP0001853_heart_inflammation | 0.77418147 |
| 122 | MP0002932_abnormal_joint_morphology | 0.77340612 |
| 123 | MP0004510_myositis | 0.73674444 |
| 124 | MP0003634_abnormal_glial_cell | 0.73431977 |
| 125 | MP0005167_abnormal_blood-brain_barrier | 0.72754099 |
| 126 | MP0005394_taste/olfaction_phenotype | 0.70967636 |
| 127 | MP0005499_abnormal_olfactory_system | 0.70967636 |
| 128 | MP0000428_abnormal_craniofacial_morphol | 0.70842339 |
| 129 | MP0002837_dystrophic_cardiac_calcinosis | 0.70280610 |
| 130 | MP0005195_abnormal_posterior_eye | 0.69873033 |
| 131 | MP0002752_abnormal_somatic_nervous | 0.69546695 |
| 132 | MP0004215_abnormal_myocardial_fiber | 0.68720010 |
| 133 | MP0006072_abnormal_retinal_apoptosis | 0.68479534 |
| 134 | MP0001664_abnormal_digestion | 0.63928495 |
| 135 | MP0005409_darkened_coat_color | 0.63780306 |
| 136 | MP0003137_abnormal_impulse_conducting | 0.63226058 |
| 137 | MP0004484_altered_response_of | 0.61934476 |
| 138 | MP0000631_abnormal_neuroendocrine_gland | 0.58762719 |
| 139 | MP0002090_abnormal_vision | 0.57371549 |
| 140 | MP0002638_abnormal_pupillary_reflex | 0.54043251 |
| 141 | MP0010769_abnormal_survival | 0.52044396 |
| 142 | MP0001943_abnormal_respiration | 0.51455692 |
| 143 | MP0005623_abnormal_meninges_morphology | 0.50934393 |
| 144 | MP0003956_abnormal_body_size | 0.49816770 |
| 145 | MP0004233_abnormal_muscle_weight | 0.49269487 |
| 146 | MP0010770_preweaning_lethality | 0.49229825 |
| 147 | MP0002082_postnatal_lethality | 0.49229825 |
| 148 | MP0010768_mortality/aging | 0.48941586 |
| 149 | MP0004043_abnormal_pH_regulation | 0.48632163 |
| 150 | MP0003861_abnormal_nervous_system | 0.46120519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.26502739 |
| 2 | Myokymia (HP:0002411) | 7.96118369 |
| 3 | Focal seizures (HP:0007359) | 6.16290029 |
| 4 | Visual hallucinations (HP:0002367) | 5.44532173 |
| 5 | Atonic seizures (HP:0010819) | 5.00777325 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.96916440 |
| 7 | Febrile seizures (HP:0002373) | 4.90627315 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.67516206 |
| 9 | Pendular nystagmus (HP:0012043) | 4.51884006 |
| 10 | Action tremor (HP:0002345) | 4.44354661 |
| 11 | Absence seizures (HP:0002121) | 4.30560722 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 4.02890095 |
| 13 | Confusion (HP:0001289) | 4.00230337 |
| 14 | Dialeptic seizures (HP:0011146) | 3.93460121 |
| 15 | Gaze-evoked nystagmus (HP:0000640) | 3.82437527 |
| 16 | Poor eye contact (HP:0000817) | 3.80761844 |
| 17 | Porencephaly (HP:0002132) | 3.79720205 |
| 18 | Broad-based gait (HP:0002136) | 3.72472116 |
| 19 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.64465880 |
| 20 | Morphological abnormality of the middle ear (HP:0008609) | 3.58045590 |
| 21 | Supranuclear gaze palsy (HP:0000605) | 3.54574136 |
| 22 | Dysdiadochokinesis (HP:0002075) | 3.45040678 |
| 23 | Short 1st metacarpal (HP:0010034) | 3.44583760 |
| 24 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.44583760 |
| 25 | Ankle clonus (HP:0011448) | 3.43140843 |
| 26 | Dysmetria (HP:0001310) | 3.39391305 |
| 27 | Impaired social interactions (HP:0000735) | 3.37510044 |
| 28 | Abnormal social behavior (HP:0012433) | 3.37510044 |
| 29 | Depression (HP:0000716) | 3.35701136 |
| 30 | Abnormality of the nasal septum (HP:0000419) | 3.33733509 |
| 31 | Pancreatic cysts (HP:0001737) | 3.26945859 |
| 32 | Pancreatic fibrosis (HP:0100732) | 3.24150898 |
| 33 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.20920578 |
| 34 | Abolished electroretinogram (ERG) (HP:0000550) | 3.18903442 |
| 35 | Anxiety (HP:0000739) | 3.15482855 |
| 36 | Hyperventilation (HP:0002883) | 3.15283075 |
| 37 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.12408023 |
| 38 | Truncal ataxia (HP:0002078) | 3.08411816 |
| 39 | True hermaphroditism (HP:0010459) | 3.03752364 |
| 40 | Impaired smooth pursuit (HP:0007772) | 3.03057202 |
| 41 | Postural instability (HP:0002172) | 3.02627105 |
| 42 | Congenital sensorineural hearing impairment (HP:0008527) | 3.01455272 |
| 43 | Amblyopia (HP:0000646) | 3.01283036 |
| 44 | Methylmalonic acidemia (HP:0002912) | 2.99665464 |
| 45 | Abnormality of the 1st metacarpal (HP:0010009) | 2.99117848 |
| 46 | Abnormality of the lower motor neuron (HP:0002366) | 2.98089715 |
| 47 | Abnormal eating behavior (HP:0100738) | 2.97235376 |
| 48 | Increased corneal curvature (HP:0100692) | 2.92573594 |
| 49 | Keratoconus (HP:0000563) | 2.92573594 |
| 50 | Scanning speech (HP:0002168) | 2.91794801 |
| 51 | Conjunctival hamartoma (HP:0100780) | 2.90734125 |
| 52 | Severe visual impairment (HP:0001141) | 2.88854793 |
| 53 | Genetic anticipation (HP:0003743) | 2.82933108 |
| 54 | Abnormality of cochlea (HP:0000375) | 2.82189802 |
| 55 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.81822412 |
| 56 | Asplenia (HP:0001746) | 2.80145293 |
| 57 | Torticollis (HP:0000473) | 2.79933072 |
| 58 | Hamartoma of the eye (HP:0010568) | 2.79095149 |
| 59 | Papilledema (HP:0001085) | 2.78914729 |
| 60 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.77652577 |
| 61 | Urinary urgency (HP:0000012) | 2.76701222 |
| 62 | Abnormality of homocysteine metabolism (HP:0010919) | 2.76647118 |
| 63 | Homocystinuria (HP:0002156) | 2.76647118 |
| 64 | Short hallux (HP:0010109) | 2.75123015 |
| 65 | Annular pancreas (HP:0001734) | 2.71671315 |
| 66 | Mutism (HP:0002300) | 2.70394059 |
| 67 | Stereotypic behavior (HP:0000733) | 2.68015185 |
| 68 | Decreased central vision (HP:0007663) | 2.67537236 |
| 69 | Intention tremor (HP:0002080) | 2.66271807 |
| 70 | Hemiplegia (HP:0002301) | 2.65871992 |
| 71 | Ventricular fibrillation (HP:0001663) | 2.64287422 |
| 72 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.63687078 |
| 73 | Focal dystonia (HP:0004373) | 2.63620594 |
| 74 | Spastic gait (HP:0002064) | 2.63321780 |
| 75 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.63288623 |
| 76 | Dysmetric saccades (HP:0000641) | 2.63286091 |
| 77 | Abnormality of secondary sexual hair (HP:0009888) | 2.63192875 |
| 78 | Abnormality of the axillary hair (HP:0100134) | 2.63192875 |
| 79 | Short phalanx of the thumb (HP:0009660) | 2.60812063 |
| 80 | Hemiparesis (HP:0001269) | 2.60515665 |
| 81 | Long nose (HP:0003189) | 2.60165161 |
| 82 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.59091398 |
| 83 | Furrowed tongue (HP:0000221) | 2.59069999 |
| 84 | Diplopia (HP:0000651) | 2.56630808 |
| 85 | Abnormality of binocular vision (HP:0011514) | 2.56630808 |
| 86 | Impaired vibratory sensation (HP:0002495) | 2.54216872 |
| 87 | Short 4th metacarpal (HP:0010044) | 2.53151808 |
| 88 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.53151808 |
| 89 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.51590852 |
| 90 | Goiter (HP:0000853) | 2.50197365 |
| 91 | Status epilepticus (HP:0002133) | 2.50038609 |
| 92 | Septo-optic dysplasia (HP:0100842) | 2.49916064 |
| 93 | Progressive inability to walk (HP:0002505) | 2.49601484 |
| 94 | Excessive salivation (HP:0003781) | 2.49574857 |
| 95 | Drooling (HP:0002307) | 2.49574857 |
| 96 | Bone cyst (HP:0012062) | 2.49510762 |
| 97 | Insidious onset (HP:0003587) | 2.48814731 |
| 98 | Termporal pattern (HP:0011008) | 2.48814731 |
| 99 | Bradykinesia (HP:0002067) | 2.47151114 |
| 100 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.45129780 |
| 101 | Epileptiform EEG discharges (HP:0011182) | 2.43763723 |
| 102 | Carpal bone hypoplasia (HP:0001498) | 2.43026853 |
| 103 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.39250681 |
| 104 | Fetal akinesia sequence (HP:0001989) | 2.38973056 |
| 105 | Abnormality of the renal collecting system (HP:0004742) | 2.38005366 |
| 106 | Cerebral inclusion bodies (HP:0100314) | 2.37666000 |
| 107 | Restlessness (HP:0000711) | 2.36558681 |
| 108 | Morphological abnormality of the inner ear (HP:0011390) | 2.36301691 |
| 109 | Stenosis of the external auditory canal (HP:0000402) | 2.35547225 |
| 110 | Neurofibrillary tangles (HP:0002185) | 2.34265018 |
| 111 | Meningioma (HP:0002858) | 2.30755062 |
| 112 | Methylmalonic aciduria (HP:0012120) | 2.30393728 |
| 113 | Craniofacial dystonia (HP:0012179) | 2.29834763 |
| 114 | EEG with generalized epileptiform discharges (HP:0011198) | 2.29390618 |
| 115 | Synostosis of carpal bones (HP:0005048) | 2.28066956 |
| 116 | Megalencephaly (HP:0001355) | 2.26882156 |
| 117 | Absent speech (HP:0001344) | 2.23075190 |
| 118 | Short femoral neck (HP:0100864) | 2.22975417 |
| 119 | Nephronophthisis (HP:0000090) | 2.22000117 |
| 120 | Cystic liver disease (HP:0006706) | 2.21671490 |
| 121 | Congenital, generalized hypertrichosis (HP:0004540) | 2.20921013 |
| 122 | Truncal obesity (HP:0001956) | 2.20473147 |
| 123 | Chorioretinal atrophy (HP:0000533) | 2.20257708 |
| 124 | Tinnitus (HP:0000360) | 2.18024284 |
| 125 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.17508159 |
| 126 | Hypsarrhythmia (HP:0002521) | 2.16723958 |
| 127 | Pheochromocytoma (HP:0002666) | 2.15051822 |
| 128 | Pointed chin (HP:0000307) | 2.13874088 |
| 129 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.13586752 |
| 130 | Lower limb muscle weakness (HP:0007340) | 2.13234724 |
| 131 | Inability to walk (HP:0002540) | 2.13089940 |
| 132 | 3-Methylglutaconic aciduria (HP:0003535) | 2.12510872 |
| 133 | Incomplete penetrance (HP:0003829) | 2.11990581 |
| 134 | Abnormality of the corticospinal tract (HP:0002492) | 2.11952306 |
| 135 | Abnormality of DNA repair (HP:0003254) | 2.11068197 |
| 136 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.09980794 |
| 137 | Gait ataxia (HP:0002066) | 2.07571327 |
| 138 | Congenital stationary night blindness (HP:0007642) | 2.07261335 |
| 139 | Myotonia (HP:0002486) | 2.06168797 |
| 140 | Optic nerve hypoplasia (HP:0000609) | 2.05999249 |
| 141 | Irregular vertebral endplates (HP:0003301) | 2.03493324 |
| 142 | Hypoplastic pelvis (HP:0008839) | 2.02623164 |
| 143 | Limb dystonia (HP:0002451) | 2.02069246 |
| 144 | Type II lissencephaly (HP:0007260) | 2.01587846 |
| 145 | Generalized myoclonic seizures (HP:0002123) | 2.01331270 |
| 146 | Bundle branch block (HP:0011710) | 2.00433806 |
| 147 | Clumsiness (HP:0002312) | 2.00293635 |
| 148 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.98901792 |
| 149 | Lower limb asymmetry (HP:0100559) | 1.97024385 |
| 150 | Resting tremor (HP:0002322) | 1.95643486 |
| 151 | Insomnia (HP:0100785) | 1.95288799 |
| 152 | Abnormality of saccadic eye movements (HP:0000570) | 1.95084739 |
| 153 | Small hand (HP:0200055) | 1.94682638 |
| 154 | Synostosis involving the elbow (HP:0003938) | 1.93371866 |
| 155 | Humeroradial synostosis (HP:0003041) | 1.93371866 |
| 156 | Neuronal loss in central nervous system (HP:0002529) | 1.92192616 |
| 157 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.91142620 |
| 158 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.91137771 |
| 159 | Gonadotropin excess (HP:0000837) | 1.90820288 |
| 160 | Lower limb amyotrophy (HP:0007210) | 1.90531251 |
| 161 | Mesomelia (HP:0003027) | 1.88979044 |
| 162 | Abnormality of the 4th metacarpal (HP:0010012) | 1.88169293 |
| 163 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.88143816 |
| 164 | Clonus (HP:0002169) | 1.87702471 |
| 165 | Fused cervical vertebrae (HP:0002949) | 1.87113233 |
| 166 | Thyroid-stimulating hormone excess (HP:0002925) | 1.86556709 |
| 167 | Abnormal EKG (HP:0003115) | 1.85378505 |
| 168 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.84551085 |
| 169 | Short tibia (HP:0005736) | 1.84212988 |
| 170 | Delusions (HP:0000746) | 1.83880674 |
| 171 | Absent thumb (HP:0009777) | 1.82591625 |
| 172 | Abnormality of the columella (HP:0009929) | 1.82420534 |
| 173 | Agitation (HP:0000713) | 1.82338164 |
| 174 | Neuroendocrine neoplasm (HP:0100634) | 1.81126015 |
| 175 | Obstructive sleep apnea (HP:0002870) | 1.80643119 |
| 176 | Polyphagia (HP:0002591) | 1.79708910 |
| 177 | Psychosis (HP:0000709) | 1.79257044 |
| 178 | Blue irides (HP:0000635) | 1.79033478 |
| 179 | Rigidity (HP:0002063) | 1.76378236 |
| 180 | Amyotrophic lateral sclerosis (HP:0007354) | 1.76313777 |
| 181 | Rapidly progressive (HP:0003678) | 1.71291704 |
| 182 | Abnormality of salivation (HP:0100755) | 1.69671719 |
| 183 | Failure to thrive in infancy (HP:0001531) | 1.68975635 |
| 184 | Limb ataxia (HP:0002070) | 1.67259810 |
| 185 | Protruding tongue (HP:0010808) | 1.65028056 |
| 186 | Deeply set eye (HP:0000490) | 1.64561728 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.93197918 |
| 2 | FRK | 4.71128871 |
| 3 | NTRK3 | 4.55663010 |
| 4 | GRK1 | 4.44460393 |
| 5 | MAP3K9 | 3.93226431 |
| 6 | ADRBK2 | 3.93011438 |
| 7 | DAPK2 | 2.94076127 |
| 8 | MAP3K4 | 2.79877118 |
| 9 | MINK1 | 2.63129267 |
| 10 | RIPK4 | 2.47581040 |
| 11 | PRKD3 | 2.29317197 |
| 12 | PAK6 | 2.27142347 |
| 13 | MAP2K7 | 2.23640573 |
| 14 | KSR2 | 2.22408202 |
| 15 | TAOK3 | 2.18548857 |
| 16 | MARK1 | 2.16344976 |
| 17 | TLK1 | 2.04980217 |
| 18 | CAMKK1 | 2.01365318 |
| 19 | NTRK1 | 1.93512114 |
| 20 | NTRK2 | 1.85717056 |
| 21 | TAF1 | 1.83452484 |
| 22 | DAPK1 | 1.82665723 |
| 23 | MAP3K12 | 1.81796966 |
| 24 | MAP2K4 | 1.79893971 |
| 25 | BMPR1B | 1.75530474 |
| 26 | NUAK1 | 1.73352651 |
| 27 | ACVR1B | 1.70686548 |
| 28 | CASK | 1.68292208 |
| 29 | SIK2 | 1.61149334 |
| 30 | CDK5 | 1.60172523 |
| 31 | INSRR | 1.59289172 |
| 32 | GRK6 | 1.58274478 |
| 33 | TNIK | 1.56184045 |
| 34 | CDK19 | 1.53650064 |
| 35 | KSR1 | 1.53580329 |
| 36 | STK38 | 1.50480238 |
| 37 | ARAF | 1.49961336 |
| 38 | GRK5 | 1.46607771 |
| 39 | PRPF4B | 1.39118198 |
| 40 | CDC7 | 1.38253405 |
| 41 | PLK2 | 1.35891543 |
| 42 | MAP3K13 | 1.33416307 |
| 43 | ZAK | 1.32332541 |
| 44 | FES | 1.29160122 |
| 45 | PRKCG | 1.26657557 |
| 46 | CAMKK2 | 1.25290967 |
| 47 | TAOK1 | 1.23873787 |
| 48 | TYRO3 | 1.21064669 |
| 49 | MAP4K2 | 1.19318101 |
| 50 | MAP3K2 | 1.19205014 |
| 51 | MAPK13 | 1.16737435 |
| 52 | PNCK | 1.16619694 |
| 53 | ERBB2 | 1.15479084 |
| 54 | PINK1 | 1.05784863 |
| 55 | UHMK1 | 1.03444354 |
| 56 | CAMK1 | 1.00245470 |
| 57 | CAMK2A | 0.98236331 |
| 58 | WNK3 | 0.95956304 |
| 59 | AKT3 | 0.95312223 |
| 60 | STK11 | 0.94941516 |
| 61 | ADRBK1 | 0.93845722 |
| 62 | BMPR2 | 0.92882657 |
| 63 | SGK223 | 0.92211292 |
| 64 | SGK494 | 0.92211292 |
| 65 | PTK2B | 0.91976103 |
| 66 | FGFR2 | 0.91813798 |
| 67 | BLK | 0.91627898 |
| 68 | RAF1 | 0.90644245 |
| 69 | CDK18 | 0.90415494 |
| 70 | CDK15 | 0.89096995 |
| 71 | CSNK1G1 | 0.87817782 |
| 72 | PRKCH | 0.85562280 |
| 73 | CDK14 | 0.84565046 |
| 74 | CAMK2B | 0.84555261 |
| 75 | PHKG1 | 0.83720930 |
| 76 | PHKG2 | 0.83720930 |
| 77 | CSNK1A1L | 0.82367445 |
| 78 | OXSR1 | 0.82031530 |
| 79 | TXK | 0.79120780 |
| 80 | CSNK1G3 | 0.79069052 |
| 81 | PDK1 | 0.78321728 |
| 82 | RET | 0.78114649 |
| 83 | CDK11A | 0.77570814 |
| 84 | SGK2 | 0.76305319 |
| 85 | CSNK1A1 | 0.76123220 |
| 86 | DYRK2 | 0.75714261 |
| 87 | SGK1 | 0.74993432 |
| 88 | LATS2 | 0.74916115 |
| 89 | MAPKAPK5 | 0.74444797 |
| 90 | TNK2 | 0.74269238 |
| 91 | LMTK2 | 0.73278484 |
| 92 | PDPK1 | 0.73129838 |
| 93 | MAPK15 | 0.72882123 |
| 94 | TIE1 | 0.72277549 |
| 95 | GRK7 | 0.70441033 |
| 96 | ALK | 0.68289811 |
| 97 | RPS6KA6 | 0.67180453 |
| 98 | VRK1 | 0.67038795 |
| 99 | SGK3 | 0.66853799 |
| 100 | MAPK4 | 0.65002692 |
| 101 | PAK3 | 0.62467027 |
| 102 | WNK4 | 0.60497006 |
| 103 | MARK2 | 0.60382818 |
| 104 | DYRK1A | 0.60041123 |
| 105 | RPS6KA5 | 0.59677716 |
| 106 | STK24 | 0.59595208 |
| 107 | CDK9 | 0.59002035 |
| 108 | BRAF | 0.57876281 |
| 109 | PRKD1 | 0.57549526 |
| 110 | WNK1 | 0.57371780 |
| 111 | FLT3 | 0.57183956 |
| 112 | RIPK1 | 0.56983300 |
| 113 | STK39 | 0.56587268 |
| 114 | VRK2 | 0.56536230 |
| 115 | MKNK2 | 0.56067660 |
| 116 | TEC | 0.54881089 |
| 117 | CAMK4 | 0.54189924 |
| 118 | IKBKB | 0.53661673 |
| 119 | MAP3K1 | 0.53475118 |
| 120 | CLK1 | 0.52820650 |
| 121 | NEK6 | 0.52729092 |
| 122 | RPS6KA3 | 0.50454132 |
| 123 | CAMK2D | 0.50162886 |
| 124 | CDC42BPA | 0.50110833 |
| 125 | PKN1 | 0.50069593 |
| 126 | MAP3K7 | 0.49059762 |
| 127 | IGF1R | 0.48819833 |
| 128 | PRKCZ | 0.48692202 |
| 129 | DAPK3 | 0.47798733 |
| 130 | CAMK2G | 0.47174198 |
| 131 | NME1 | 0.46184745 |
| 132 | MAPK10 | 0.45474574 |
| 133 | CDK3 | 0.45102645 |
| 134 | STK38L | 0.44855826 |
| 135 | PRKACA | 0.44775348 |
| 136 | CAMK1D | 0.44241539 |
| 137 | FYN | 0.44110925 |
| 138 | CAMK1G | 0.44102113 |
| 139 | FGR | 0.43782032 |
| 140 | CSNK1G2 | 0.43337496 |
| 141 | BRSK1 | 0.43258824 |
| 142 | MAP2K6 | 0.42692459 |
| 143 | CCNB1 | 0.42599068 |
| 144 | CSNK1D | 0.42593192 |
| 145 | NLK | 0.40463497 |
| 146 | SIK3 | 0.40229098 |
| 147 | PRKCE | 0.39952438 |
| 148 | DMPK | 0.38847317 |
| 149 | MAP2K2 | 0.36638942 |
| 150 | MAP2K1 | 0.36630767 |
| 151 | NEK9 | 0.35782246 |
| 152 | ROCK2 | 0.34517104 |
| 153 | FER | 0.32245245 |
| 154 | PRKCB | 0.32119425 |
| 155 | PRKD2 | 0.31999039 |
| 156 | PRKCA | 0.30348575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.77950201 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.28701780 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.94354505 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.83882985 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.76944546 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.70193944 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.68232404 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.64024031 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.55406653 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.54986558 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.32001291 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.26410754 |
| 13 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.19110079 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.16955589 |
| 15 | Melanoma_Homo sapiens_hsa05218 | 2.06010926 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 2.04094454 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.03340286 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.97804092 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.94790062 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.93992956 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.82600876 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.74786986 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.74756220 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.72914363 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.72146654 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.70498355 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.66491684 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.60901802 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.55682658 |
| 30 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.54799696 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.48799189 |
| 32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.45472365 |
| 33 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.42500333 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.38388361 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.37218998 |
| 36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.35063739 |
| 37 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.34561854 |
| 38 | Gap junction_Homo sapiens_hsa04540 | 1.34557938 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.33718786 |
| 40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.28315686 |
| 41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.28204549 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28071199 |
| 43 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.24948289 |
| 44 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.24023550 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.23971872 |
| 46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.23186806 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.19974889 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.15420737 |
| 49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.14909866 |
| 50 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14581089 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.14379980 |
| 52 | Glioma_Homo sapiens_hsa05214 | 1.14110587 |
| 53 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.12445835 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.11938604 |
| 55 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08226526 |
| 56 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03827284 |
| 57 | Melanogenesis_Homo sapiens_hsa04916 | 1.03130685 |
| 58 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.01049555 |
| 59 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.00301206 |
| 60 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.98931682 |
| 61 | Axon guidance_Homo sapiens_hsa04360 | 0.97050232 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96235256 |
| 63 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.94955003 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.92383551 |
| 65 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.90183864 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89645727 |
| 67 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.87600221 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.83774093 |
| 69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.82090113 |
| 70 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.80627578 |
| 71 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79338503 |
| 72 | Phototransduction_Homo sapiens_hsa04744 | 0.77117057 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75825103 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74256189 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73886489 |
| 76 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.72661566 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72433069 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.72001106 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70630539 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69171829 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69063354 |
| 82 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.68499731 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68127783 |
| 84 | DNA replication_Homo sapiens_hsa03030 | 0.67582642 |
| 85 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.66808213 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66010833 |
| 87 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64574986 |
| 88 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62781487 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62379264 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60034280 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59821077 |
| 92 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.59141713 |
| 93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.58655978 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58469400 |
| 95 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58402145 |
| 96 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.55475658 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54772556 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54553850 |
| 99 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53963389 |
| 100 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53760512 |
| 101 | Bile secretion_Homo sapiens_hsa04976 | 0.53685400 |
| 102 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52368723 |
| 103 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.52260801 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49311871 |
| 105 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.48554507 |
| 106 | Basal transcription factors_Homo sapiens_hsa03022 | 0.48004244 |
| 107 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46715093 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.46509430 |
| 109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46045441 |
| 110 | Alcoholism_Homo sapiens_hsa05034 | 0.44778318 |
| 111 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44430242 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44278699 |
| 113 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43312834 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43280419 |
| 115 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42558902 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.42431991 |
| 117 | RNA degradation_Homo sapiens_hsa03018 | 0.42148906 |
| 118 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41758349 |
| 119 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.40495386 |
| 120 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40291744 |
| 121 | Asthma_Homo sapiens_hsa05310 | 0.39851524 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.39553187 |
| 123 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39045964 |
| 124 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.37888293 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37830200 |
| 126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37500041 |
| 127 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37428400 |
| 128 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37384177 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35551444 |
| 130 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.35155270 |
| 131 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34929037 |
| 132 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.34928578 |
| 133 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34515671 |
| 134 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.34200923 |
| 135 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34187638 |
| 136 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34099347 |
| 137 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33971534 |
| 138 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32887451 |
| 139 | Alzheimers disease_Homo sapiens_hsa05010 | 0.30915520 |
| 140 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.30344932 |
| 141 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28205337 |
| 142 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27288883 |
| 143 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25509173 |

